Resuscitation Plus (Jun 2024)

Emergency front-of-neck access in cardiac arrest: A scoping review

  • Mohammed Aljanoubi,
  • Abdulkarim A. Almazrua,
  • Samantha Johnson,
  • Ian R Drennan,
  • Joshua C. Reynolds,
  • Jasmeet Soar,
  • Keith Couper,
  • Katherine M. Berg,
  • Bernd W. Böttiger,
  • Yew Woon Chia,
  • Conor Crowley,
  • Sonia D'Arrigo,
  • Charles D. Deakin,
  • Shannon M. Fernando,
  • Rakesh Garg,
  • Asger Granfeldt,
  • Brian Grunau,
  • Karen G. Hirsch,
  • Mathias J. Holmberg,
  • Eric Lavonas,
  • Carrie Leong,
  • Peter J. Kudenchuk,
  • Peter Morley,
  • Ari Moskowitz,
  • Robert Neumar,
  • Tonia C. Nicholson,
  • Nikolaos Nikolaou,
  • Jerry P. Nolan,
  • Brian O'Neil,
  • Shinichiro Ohshimo,
  • Michael Parr,
  • Helen Pocock,
  • Claudio Sandroni,
  • Tommaso Scquizzato,
  • Markus Skrifvars,
  • Neville Vlok,
  • Michelle Welsford,
  • Carolyn Zelop

Journal volume & issue
Vol. 18
p. 100653

Abstract

Read online

Background: Airway management is a core component of the treatment of cardiac arrest. Where a rescuer cannot establish a patent airway to provide oxygenation and ventilation using standard basic and advanced airway techniques, there may be a need to consider emergency front-of-neck airway access (eFONA, e.g., cricothyroidotomy), but there is limited evidence to inform this approach. Objectives: This scoping review aims to identify the evidence for the use of eFONA techniques in patients with cardiac arrest. Methods: In November 2023, we searched Medline, Embase, and Cochrane Central to identify studies on eFONA in adults. We included randomised controlled trials, non-randomised studies, and case series with at least five cases that described any use of eFONA. We extracted data, including study setting, population characteristics, intervention characteristics, and outcomes. Our analysis focused on four key areas: incidence of eFONA, eFONA success rates, clinical outcomes, and complications. Results: The search identified 21,565 papers, of which 18,934 remained after de-duplication. After screening, we included 69 studies (53 reported incidence, 40 reported success rate, 38 reported clinical outcomes; 36 studies reported complications). We identified only one randomised controlled trial. Across studies, there was a total of 4,457 eFONA attempts, with a median of 31 attempts (interquartile range 16–56.5) per study. There was marked heterogeneity across studies that precluded any pooling of data. There were no studies that included only patients in cardiac arrest. Conclusion: The available evidence for eFONA is extremely heterogeneous, with no studies specifically focusing on its use in adults with cardiac arrest.

Keywords